Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Zunaira Akbar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The University of Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal, Candida, Candidiasis. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The increased consumption of antifungal agents increases the emergence of resistant fungal strains among immunocompromised patients. The present study aims to determine the antifungal consumption and resistance pattern among adult and pediatric cancer patients with systemic Candida infections.
Method
A descriptive, retrospective study was conducted by reviewing admitted patients' electronic medical records from 2019 to 2023. Consumption was estimated using Days of Therapy (DOT) metrics. Culture reports of Candida‐positive isolates were collected from the hospital microbiology laboratory to determine the resistance pattern of Candida species.
Results
Consumption of antifungals showed a declining trend, with highest consumption of oral voriconazole (mean DOT/1000 pt. days 18653.49) and oral fluconazole (mean DOT/1000 pt. days 15258.14). Candida albicans was the most isolated pathogen 768 (53.60%) and among all Candida species, major resistance was found in C. tropicalis 58 (4.05%). All Candida species except C. parapsilosis and C. guilliermondii exhibited more resistance to fluconazole.
Conclusion
The findings indicated that the number of resistant isolates is clinically important 133 (9.2%) in the immunocompromised population, which underscores the necessity of conducting culture sensitivity analyses of antifungals. This approach is crucial for early detection and mitigation of antifungal resistance and optimizing therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The University of Lahore, Lahore, Pakistan.
- Riphah Institute of Pharmaceutical Sciences, Riphah International University, Lahore, Pakistan.
- Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
- Department of Pharmacy, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka, Saudi Arabia.
ORCID-Profile: Zunaira Akbar, Hasan Ejaz
Zitieren
APA
Akbar, Z., Aamir, M., Saleem, Z., Niazi, M. R. K., Ejaz, H., Alruwaili, M., & Abosalif, K. (2025). Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70022
Vancouver
Akbar Z, Aamir M, Saleem Z, Niazi MRK, Ejaz H, Alruwaili M, et al. Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70022
BibTeX
@article{Akbar2025,
author = {Akbar, Zunaira and Aamir, Muhammad and Saleem, Zikria and Niazi, Muhammad Rehan Khan and Ejaz, Hasan and Alruwaili, Muharib and Abosalif, Khalid},
title = {Antifungal Resistance Among Candida Species: Diagnostic and Clinical Challenges in Specialized Cancer Care Hospital of Lahore},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70022}
}
EUVIMED